← Back to Search

Improved Care for Pulmonary Embolism

N/A
Waitlist Available
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months pre-intervention, up to 18 months post-intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new way to improve the treatment of patients with pulmonary embolism to see if it can help avoid unnecessary hospital stays.

Who is the study for?
This trial is for individuals who arrive at the emergency department with a pulmonary embolism (PE), which is a blockage in one of the lung's arteries. The study aims to include those who might benefit from improved care processes.
What is being tested?
The intervention being tested involves new procedures for managing PE patients in the emergency department, with a focus on reducing unnecessary hospital admissions while maintaining patient safety and quality of care.
What are the potential side effects?
Since this trial focuses on health care management rather than medication or medical procedures, there are no direct side effects associated with it. However, changes in care may affect patient experience.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months pre-intervention, up to 18 months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months pre-intervention, up to 18 months post-intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in proportion of patients discharged home from Emergency Department (ED)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: MEDIC siteExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,934 Previous Clinical Trials
47,792,262 Total Patients Enrolled
19 Trials studying Pulmonary Embolism
149,300 Patients Enrolled for Pulmonary Embolism
University of MichiganLead Sponsor
1,853 Previous Clinical Trials
6,433,011 Total Patients Enrolled
1 Trials studying Pulmonary Embolism
5,000 Patients Enrolled for Pulmonary Embolism
Geoff BarnesStudy ChairUniversity of Michigan
~9 spots leftby Aug 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top